Video / Articles by Patrick Dixon - 24 million requests in year - 10 million visitors - Conference Speech/Event?
The
Future of Health
News and videos of new kind of world
How scientists will slow down or stop ageing in humans - Video
Comment by Dr Patrick Dixon on science of ageing, health care, life expectancy, medical advances, pensions, retirement, lifestyles and government policy.
WAIT FOR PAGE TO LOAD - PRESS PLAY - MAY NEED TO PRESS AGAIN AND WAIT
Source: UC Berkely 1997
What if tables for length of life are wrong
- and survival is about to jump by 5-10%? Answer: profound impact
on insurance industry, pensions, and society as a whole. More
- see future of medicine.
Inflammation may be a much more important factor in
developing heart disease than formerly realised. Heart
disease is multifactorial and complex, and no single theory seems
to fit all the data. For example, many people with normal cholesterol
get heart disease. Indeed half of all those who get heart attacks
have cholesterol levels below 5.2 millimolews per litre (widely
regarded as the safe limit). New links with general inflammation
may explain why some researchers believe that infection with helicobacter
pylori (the bug causing many stomach ulcers), cytomegalovirus,
herpes simplex and helatitis A can all increase the risk of heart
disease. New Scientist 11 January 2003
Expect huge investment in neuroscience by pharmaceutical
companies over the next decade following progress in
the 1990s in understanding brain physiology and disease mechanisms.
Merck investment for example has jumped from 10% in 1995 to 30%
in 2003. Areas to watch: prediction using gene secreening and
new diagnostics, taking preventative action, more effective treatments.
Expect new generations of antidepressants blocking uptake of serotonin
and noradrenaline (dual uptake) with faster action and wider use.
Asthma cases worldwide have increased by 50% every decade
for unknown reasons, but the rise may be stopping in
Europe - especially Switzerland. Research conducted at Basle University
- work presented at European Respiratory Society annual conference
2002.
7,000 people every day die of malaria - a huge
unsolved medical challenge. Only four drugs developed by the pharmaceutical
industry in the last 20 years have been developed against malaria,
yet malaria could become as rare as polio if an effective vaccine
can be found. In 2002 there were just 480 polio cases - compared
to 350,000 in 1988 - following global vaccination campaigns. The
trouble is that malaria vaccine is not a great strategy for making
money - if a company is successful they will be under pressure
to give the patents away as a gift to the most vulnerable nations.
Future of biotechnology, genetics, health care, pharmaceutical industry Dr Patrick Dixon lecture to biotech venture capital investors about future medicine and health care, gene therapy, biotechnology, and the pharmaceutical industry. Dr Dixon is a physician and trends analyst.
WAIT FOR PAGE TO LOAD - PRESS PLAY - MAY NEED TO PRESS AGAIN